News

CENTEGIX® Platform Partner Program Surges to 80 Partners Driving Accelerated Emergency Response and Increased ROI on Safety Investments

Program connects trusted safety technologies into the CENTEGIX Safety Platform™, delivering more value from existing systems and enabling faster, coordinated…

6 months ago

OncoHost Named Gold Winner in 2025 Merit Awards for Business in Research & Development

BINYAMINA, Israel and CARY, N.C., July 9, 2025 /PRNewswire/ -- OncoHost, a technology company transforming the approach to precision medicine…

6 months ago

Aktiia’s Hilo Band Becomes First Cuffless Blood Pressure Monitor Cleared by FDA for Over-the-Counter Use

The FDA-cleared G0 Blood Pressure Monitoring System - marketed as Hilo Band - will bring cuffless blood pressure monitoring to…

6 months ago

Azara Healthcare Completes NCQA HEDIS® Health Plan Measure Certification Program™ for MY2025 HEDIS® Measures

BURLINGTON, Mass., July 9, 2025 /PRNewswire/ -- Azara Healthcare, the Best in KLAS provider of population health and value-based care solutions, announced…

6 months ago

Nabla and Navina Announce Strategic Partnership to Supercharge Clinician Workflows with Clinical Intelligence and Ambient AI

As value-based care demands more from physicians, the partnership helps providers close care gaps, improve audit-ready documentation and reimbursement, and…

6 months ago

NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports

NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

6 months ago

Hemostemix Oversubscribed, Closing $2,700,000 Private Placement and Settles $400,000 of Debt at $0.20 per Share

Calgary, Alberta--(Newsfile Corp. - July 9, 2025) - Hemostemix Inc's (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

6 months ago

Apollo Biowellness, Inc., Outlook for the Remainder of 2025

North Bergen, New Jersey--(Newsfile Corp. - July 9, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company"), as previously…

6 months ago

INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing

SARASOTA, Fla., July 09, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare…

6 months ago

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”),…

6 months ago